Clinuvel

Toktok

Well-known member
Doorgh.
Sleeping pills are.still the best antidote for our daily wave watching and analysis.

If I look back 15 years the SP was only 1 AUD,. The company just starting a new route and cancelling cosmetic and off label from the vocabulary.
Today cuv is sustained profitable, pays a yearly dividend and has multiple approvals and sales on two continents at least. SP is 28aud. That's a 30 bagger for some. Cuv now has to show it can keep growing and control spending over the next years and come out a diversified and vertically integrated group. I think they can do it.

Nearmap has some interesting statistical similaritiy/correlation to cuv.
SP rise and implosion in the past 3 months.
Daily trading pattern is almost a copy of cuv.
Company news very positive and strong growth shown.
Shorting at 4pct for both.
G
The gamestop shorting scenario is not unique but multiplied all over the world. Sharetease doesn't have the firepower of Reddit yet.

Clinuvel needs to get over Mickey mouse level of trade volumes. Only then the price will be formed by the market and not played with by a minority. I hope that at some point in 2022 cuv will follow in the footsteps of EPP patients and step out of the shadows starting to attract some global and sustained investor interest. Time for a Nasdaq listing?
 

Dr Wally

Well-known member
After decades (a fKing lifetime no less) left hanging regularly without news (mostly babble , without constant progress, seemingly without a coherent plan, always 2-3 years from glory. WTF!!

We saw what happened after positive news of growing revenues came to light but since then nothing concrete has eventuated

(only a measly six AIS patients in phase 1 trials: after decades ffs!!)

causing a tonne of confusion and breading much uncertainty: the prime conditions for shorters and manipulation to profit (once again!!) at long’s expense.

1- scoundrel authorities have utterly failed this drug and society in general. It rarely gets a mention but it’s the primary cause of the decades wasted here.

2- weak fearful management have also failed, doing sweet F all in regards to showing some fight in pushing Scenesse’s incredible safety and efficacy and skin cancer preventing case forward and dispelling the untruths and downplaying of efficacy by rotten authorities.

Silence by this CEO once again in the final months of yet another year down the drain is no doubt communicating a big F U to loyal long term shareholders.

The man has one goal: self enrichment and everything and everyone else comes a distant 2nd to that goal.

2022: time to get a fking grip PW and grow a pair. Speak up for this great cancer preventing drug and let the world know what’s been holding up progress for sooooooooo fking long.

This utter BS mystical fantasy ride has gone on far too long.
 
Last edited:

fozz

Well-known member
Meanwhile in the office:

MB: Hey guys i'm copping a lot of heat from those pesky people who own most of our company, talking about short attack and do something, do anything.
LH: There is no short attack, who ever heard of such nonsense we are a serious company.
DK: Cough, cough, ahem, there is too, Dr. W said it was a short attack at the end of the AGM.
LH: Its definitely a short attack no question about it lets call Europe and find out what to do.
DK: Get onto it MB.
(5 mins later..)
MB: Hey guys I just spoke to the gang and all the directors and PW have been having a meeting about the very same thing. Everyone was saying lets do whatever we can to protect the shareholders, our charter prioritises there interests we must make them No 1. They were in the process of making a punchy media release, contacting the media for interviews and even talking about buying back some shares.
(long pause)
LH and DK: HAHAHAHAHAHAHAHAHAHA your a classic MB always coming up with good jokes.
MB: Ok would you believe there was a couple of them seriously discussing putting out an old media release and maybe another interview with those guys in Germany.
DK and LH: HAHAHA good one but Nope.
MB: Oh well, we did have a quick chat about it and there was something about first certainty and then speaking about it, and something about very important about understanding ones motives and something about happy in the end. Oh well guess we must carry on.


*** just a bit of light hearted take on the situation*** I think we all know the people in the company who are never mentioned on the forums actually do a great job and should be rewarded well by clinuvel, some of the strategic stuff and inability to respond to short attacks is more concerning
 

endymion96

2nd Longest Active Member
@ChrizzlyAdams I would also say that if I didn't believe stimulation of MCR1 was not gonna actually work to decrease systemic inflammation. Since it does, your observation is incorrect. Spana isn't conning anyone in my opinion.
 
Last edited:

killipso35

Well-known member
It's a bad macro environment right now hard to point blame at any one thing about CUV price.
All I know is that market is creeping back into BUY territory, not just for CUV but a lot of great companies out there. What to buy? More CUV? I'm probably loaded up enough in portfolio but very tempted to grab more. For those looking for a quicker buck, I recommend ETH, and Roulette.
 

MrWalker

Active member
It's a bad macro environment right now hard to point blame at any one thing about CUV price.
All I know is that market is creeping back into BUY territory, not just for CUV but a lot of great companies out there. What to buy? More CUV? I'm probably loaded up enough in portfolio but very tempted to grab more. For those looking for a quicker buck, I recommend ETH, and Roulette.
Mate your words may have been taken heed ....thats a fairly nice start to a day flooded with green ....
 

ironbark222

Well-known member
It's a bad macro environment right now hard to point blame at any one thing about CUV price.
All I know is that market is creeping back into BUY territory, not just for CUV but a lot of great companies out there. What to buy? More CUV? I'm probably loaded up enough in portfolio but very tempted to grab more. For those looking for a quicker buck, I recommend ETH, and Roulette.
Was that financial advice
 

CUV Quote (Yesterday's close)

Time: 10:40AM AEDT
Price: 22.42
Volume: 39626
Top